To examine psychosocial interventions for improving medication adherence, focusing on promising initiatives, reasonable standards for conducting research in this area, and implications for clinical practice.
A total of 39 studies (n=3,972) reported in 45 articles were included: 33 were randomised (n=3,561) and 6 were nonrandomised (n=411). There were 4 studies (all randomised) of individual patient interventions (n=249), 4 studies (two randomised, two non-randomised) of group interventions (n=353), 12 studies (all randomised) of family interventions, 10 studies (six randomised, four non-randomised) of community-based interventions and 9 studies (all randomised) of mixed modality interventions.
Thirteen studies (33%) reported significant intervention effects. Nine (69%) of these found improved clinical outcomes in the intervention group at follow-up, including fewer psychiatric symptoms (6 studies), fewer hospitalisations (1 study), fewer days in hospital (2 studies) and prolonged or extended community tenure (2 studies).
Among the 33 random assignment studies, significant effects were found in 2 of the 4 studies of individual interventions, 3 of the 12 studies of family interventions, 3 of the 6 studies of community interventions, and 3 of the 9 studies with mixed treatment modalities. Among the 6 studies without random assignment, one of four community interventions and one of two group interventions reported significant improvement in adherence in the intervention groups.
Psycosocial interventions administered to individuals or families generally did not improve adherence. Family therapy alone did not have a large effect on adherence. Behavioural interventions and cognitive techniques targeting the patients' attitudes towards medication were more effective at improving adherence. There was some evidence that community treatment improved adherence.
Interventions targeted specifically to problems of nonadherence were more likely to be effective (55%) than were more broadly based treatment interventions (26%). Four of the eight successful interventions that did not specifically focus on nonadherence involved an array of supportive and rehabilitative community-based services.
Authors' conclusions
Psychoeducational interventions without accompanying behavioural components and supportive services are not likely to be effective in improving medication adherence in schizophrenia. Models of community care, such as assertive community treatment and interventions based on principles of motivational interviewing, are promising.
CRD commentary
The objective of the review was clear and the inclusion criteria were appropriate. The literature search was thorough with attempts to identify unpublished literature. However, by limiting the review to English-language studies, relevant studies could have been missed and the findings might be influenced by language bias. Since the validity of the included studies was not assessed, it is unclear whether the results of the studies and the synthesis of them are reliable. A narrative synthesis was appropriate given the differences between the studies. The authors did not describe how the data were extracted, so it is not possible to determine whether steps were taken to minimise bias in this process. The authors' conclusions should be interpreted in light of these limitations.
